Research Article
Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up
Table 2
Medical therapy and interventions.
| Medical therapy and interventions (%) |
| Drugs | Epinephrine | 27 | Norepinephrine | 52.6 | Dobutamine | 90.8 | Diuretics | 69.7 |
| Interventions | Coronary angiography | 39.5 | Urgent revascularisation | 27.6 | Mechanical circulatory support | 5.9 | Invasive ventilation | 34.1 | Dialysis | 11.2 | Noninvasive ventilation | 15.9 | Intra-aortic balloon pump | 3.3 |
| Length (days) (mean ± IQR) | Duration of inotropics support | 7.8 ± 6.8 | Duration of intensive care unit stay | 9.3 ± 7.5 | Duration of resuscitation unit stay | 9.7 ± 8.7 |
|
|